Post-operative spread of small cell glioblastoma to the subcutaneous tissue via craniotomy defect in a 9-year-old boy: An exceptionally rare case report and review of the literature

9岁男孩术后小细胞胶质母细胞瘤经开颅缺损扩散至皮下组织:一例极其罕见的病例报告及文献复习

阅读:1

Abstract

INTRODUCTION AND IMPORTANCE: Glioblastoma multiforme (GBM), a grade 4 astrocytoma, represents a predominant malignant primary tumor within the central nervous system (CNS) and is known for its dismal prognosis. While extremely uncommon in pediatric cases, the small cell glioblastoma (scGBM) variant poses diagnostic challenges due to overlapping histopathological features with other intracranial tumors. CASE PRESENTATION: We present the case of a 9-year-old Persian boy who underwent a craniotomy due to a malignant brain tumor. The histopathological examination, followed by ancillary immunohistochemical and molecular studies, led to the rare diagnosis of scGBM. Following a course of 32-session adjuvant radiotherapy, the tumor recurred with a peculiar manifestation, a subcutaneous mass at the previous surgical site, as a result of recurrent tumor invasion through craniotomy defect. CLINICAL DISCUSSION: Small-cell glioblastoma (scGBM) presents aggressive features, often misdiagnosed as other tumors. A rare pediatric occurrence, scGBM requires careful histopathological and molecular evaluations. Treatment aligns with classic GBM protocols, but prognosis is poor, with overall survival ranging from 5 to 23 months. CONCLUSION: The case highlights the diagnostic intricacies in distinguishing scGBM from other morphologically similar intracranial tumors, especially in pediatric patients. The report contributes to the limited literature on scGBM in the young population, emphasizing the significance of refined diagnostic approaches for accurate diagnosis and appropriate succeeding treatment for the best patient result.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。